Total Funding
71
71
Total FundingSeries A raised
Growth Score
-6 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
40757
Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions.
- Jacob Jacobsen: Founder, Chief Scientific Officer
- Marc Caron: Co-founder
About the Company
Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions. It aims to develop and commercialize EVX-101 to treat patients suffering from disabling, common, and costly neuropsychiatric conditions for which current therapies are inadequate, in particular depression.
The
company was established in 2013 and is based in Raleigh, North Carolina.
